All posts tagged Watson

Generic drugs

Generic drug firm Watson completes acquisition of Actavis

US generic drugs maker Watson Pharmaceuticals Inc (NYSE:WPI) said it had finalised the acquisition of Swiss-Icelandic peer Actavis Group. The parties sealed the definitive agreement in April and received clearance by the European Commission in October. The merged company will …

Continue Reading...
Euro in crisis

US-based Watson seals a deal to acquire Icelandic generic drugmaker Actavis

US generic drugs maker Watson Pharmaceuticals Inc (NYSE:WPI) has reached a deal to take over Icelandic peer Actavis Group for an initial price of EUR4.25bn (USD5.6bn), plus a

Powered by WordPress